Renal sodium retention complicating alcoholic liver disease: relation to portosystemic shunting and liver function.
The aim of this study was to determine whether liver function and portosystemic shunting are related to renal sodium retention in alcoholic liver disease. Twenty-three studies were performed; 10 patients had ascites. Liver function was assessed from the plasma elimination rates of antipyrine, caffeine and stable isotopes of cholic acid, the latter administered both orally [2,2,4,4-2H] and intravenously [24-13C]. Portosystemic shunt fraction was calculated as the ratio of the intravenous and oral clearances of the isotopes of cholic acid. Portosystemic shunt fraction was similar in patients with and without ascites (61% +/- 16% vs. 64% +/- 11%) and unrelated to urinary sodium excretion in patients with ascites (r = -0.145). Patients with ascites had significantly lower elimination rates of all administered compounds as compared with patients without ascites (antipyrine = 0.012 +/- 0.007 vs. 0.031 +/- 0.016/hr, p less than 0.001; caffeine = 0.014 +/- 0.013 vs. 0.061 +/- 0.041/hr, p less than 0.002; intravenous cholic acid = 1.355 +/- 0.442 vs. 2.284 +/- 0.885/hr, p = 0.005; orally administered cholic acid = 2.178 +/- 0.841 vs. 4.056 +/- 1.837/hr, p = 0.007). However, urinary sodium excretion in patients with ascites was not related to the elimination constants of these compounds (r = 0.360, 0.319, 0.067, -0.073, respectively). Ascites complicating alcoholic liver disease is associated with impaired liver function but not the extent of portosystemic shunting.
Department of Medicine, University of Colorado Health Sciences Center, Denver General Hospital 80204.
W G
WG
Rector
F
F
Lewis
A D
AD
Robertson
G T
GT
Everson
D000328:Adult; D000983:Antipyrine; D001201:Ascites / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D002110:Caffeine; D019826:Cholic Acid; D002793:Cholic Acids; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D008099:Liver / Q000503:physiopathology*; D008108:Liver Diseases, Alcoholic / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D008111:Liver Function Tests / Q000379:methods; D008297:Male; D011168:Portal System / Q000503:physiopathology*; D012964:Sodium / Q000378:metabolism*
D002793:Cholic Acids; D002110:Caffeine; D012964:Sodium; D019826:Cholic Acid; D000983:Antipyrine